Spyre Therapeutics, Inc. SYRE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $85.72M-4.1% | $89.42M-52.7% | $189.22M+420% | $36.42M+114% | ||
| $670.81M+30.6% | $513.67M+242% | $150.38M+621% | $20.85M-73.3% | ||
| $777.78M+27.8% | $608.47M+78.2% | $341.53M+449% | $62.26M-37.0% | ||
| $777.78M+27.8% | $608.48M+78.0% | $341.86M+381% | $71.14M-35.3% | ||
| $58.69M+8.6% | $54.06M+69.1% | $31.98M+118% | $14.66M-27.2% | ||
| $26.68M-70.6% | $90.68M+23.7% | $73.29M+252% | $20.84M-19.8% | ||
| 400M+3,076,823% | 13K+30.0% | 10K+66.7% | 6K+20.0% | ||
| -$1.13B-16.0% | -$972.43M-27.2% | -$764.41M-79.6% | -$425.62M-24.5% | ||
| $715.24M+38.1% | $517.8M+181% | $184.02M+266% | $50.31M-40.1% | ||
| $777.78M+27.8% | $608.48M+78.0% | $341.86M+381% | $71.14M-35.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Spyre Therapeutics, Inc.'s total assets?
- Spyre Therapeutics, Inc. (SYRE) holds $764.0M in total assets, up 34.1% year over year.
- How much cash does Spyre Therapeutics, Inc. have?
- Spyre Therapeutics, Inc. holds $97.2M in cash and equivalents.
- Can Spyre Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 8.97 — current assets exceed current liabilities.
- Where does Spyre Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Spyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.